de Jong, Jan
Haddish-Berhane, Nahor
Hellemans, Peter
Jiao, James
Sukbuntherng, Juthamas
Ouellet, Daniele
Funding for this research was provided by:
Janssen Research and Development
Article History
Received: 19 February 2018
Accepted: 28 May 2018
First Online: 7 June 2018
Compliance with ethical standards
:
: de Jong, Haddish-Berhane, Hellemans, Jiao, and Ouellet are employees of Janssen Research & Development and hold stock in the company. Sukbuntherng is an employee of Pharmacyclics LLC and holds AbbVie stock.
: This study was conducted in accordance with the ethical principles that have their origin in the Declaration of Helsinki and are consistent with Good Clinical Practices and applicable regulatory requirements. The study protocol was approved by the Independent Ethics Committee or Institutional Review Board at the study center. The study is registered at clinicaltrials.gov (NCT02638116).
: Informed consent was obtained from all individual participants included in the study.